Taiho Oncology and Servier to Present Data on LONSURF® (trifluridine and tipiracil) and Key Investigational Compound TAS-120 at ESMO 20th World Congress on Gastrointestinal Cancer 2018

Good results from the drug Lonsurf for treating metastatic gastric cancer in a phase 3 trial are being presented this week at the ESMO 20th World Congress on Gastrointestinal Cancer (tag) 2018 in Barcelona, Spain.